Literature DB >> 1127574

Pharmocokinetics of hexobarbital in man after intravenous infusion.

D D Breimer, C Honhoff, W Zilly, E Richter, J M van Rossum.   

Abstract

The plasma levels of hexobarbital in humans were determined during and after a 30-min or 60-min zero-order intravenous infusion. Hexobarbital kinetics could be described by conceiving the body to exhibit two compartments. The plasma concentrations were fitted to the postinfusion equation and the parameters intrinsic to the two-compartment open model were estimated. The elimination half-life varied considerably among the 14 individuals (160-441-min), which could mainly be explained by the greatly varying metabolic clearance of the compound (123-360 ml/min). The apparent volume of distribution per kilogram of body weight was relatively constant (1.10 plus or minus 0.12 liters/kg).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127574     DOI: 10.1007/bf01066591

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  10 in total

1.  [DIFFERENCES IN MICROSOMAL OXIDATION AND ACETYLATION OF DRUGS IN DIFFERENT SPECIES AND RACES].

Authors:  M SIEGERT; B ALSLEBEN; W LIEBENSCHUETZ; H REMMER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

2.  Physiological disposition and chemical fate of thiobarbiturates in the body.

Authors:  B B BRODIE
Journal:  Fed Proc       Date:  1952-06

3.  Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector.

Authors:  D D Breimer; J M Van Rossum
Journal:  J Chromatogr       Date:  1974-01-30

4.  [Hexobarbital plasma levels in patients with acute hepatitis during a continuous infusion of hexbarbital].

Authors:  W Zilly; D Brachtel; E Richter
Journal:  Klin Wochenschr       Date:  1973-04-01

5.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

6.  Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

7.  Studies on the absorption rate of barbiturates in man.

Authors:  J Sjögren; L Sölvell; I Karlsson
Journal:  Acta Med Scand       Date:  1965-11

8.  Letter: Pharmacokinetics of (+)-, (-)- and (plus or minus)-hexobarbitone in man after oral administration.

Authors:  D D Breimer; J M van Rossum
Journal:  J Pharm Pharmacol       Date:  1973-09       Impact factor: 3.765

9.  [Barbiturate tolerance in patients with acute hepatitis].

Authors:  E Richter; W Zilly; D Brachtel; S Becker
Journal:  Dtsch Med Wochenschr       Date:  1972-02-18       Impact factor: 0.628

10.  Ultra-short-acting barbiturates as oral hypnotic agents in man.

Authors:  M T Bush; G Berry; A Hume
Journal:  Clin Pharmacol Ther       Date:  1966 May-Jun       Impact factor: 6.875

  10 in total
  19 in total

Review 1.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

3.  Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.

Authors:  W Zilly; D D Breimer; E Richter
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

4.  Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.

Authors:  D D Breimer; A G de Boer
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 5.  Pharmacokinetics of haemoperfusion for drug overdose.

Authors:  S Pond; J Rosenberg; N L Benowitz; S Takki
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

6.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

7.  Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.

Authors:  J H Schellens; J H van der Wart; M Danhof; E A van der Velde; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

8.  Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.

Authors:  P Veng-Pedersen; W Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

9.  Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.

Authors:  G Heinemeyer; H J Gramm; W Simgen; R Dennhardt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.

Authors:  D A Smith; M H Chandler; S I Shedlofsky; P J Wedlund; R A Blouin
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.